Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT3697 | Organism | Leishmania tropica | Leishmania tropica | ED50 | = | 0.076 | nM | 6471066 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Inhibition | = | 8 | % | 11959007 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Inhibition | = | 28 | % | 11959007 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Ki | = | 2000000 | nM | 11959007 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Inhibition | = | 11 | % | 11959007 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Inhibition | = | 22 | % | 11959007 |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Ki | = | 1800000 | nM | 11959007 |
NPT3129 | Organism | Eimeria tenella | Eimeria tenella | MIC | = | 20 | ug/ml | 7131482 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC321393 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.773 | Intermediate Similarity | NPC54320 |
0.773 | Intermediate Similarity | NPC313754 |
0.773 | Intermediate Similarity | NPC311197 |
0.7692 | Intermediate Similarity | NPC222174 |
0.7669 | Intermediate Similarity | NPC52238 |
0.7593 | Intermediate Similarity | NPC207633 |
0.7471 | Intermediate Similarity | NPC125659 |
0.7471 | Intermediate Similarity | NPC168702 |
0.7468 | Intermediate Similarity | NPC321929 |
0.7412 | Intermediate Similarity | NPC261595 |
0.7412 | Intermediate Similarity | NPC33382 |
0.7368 | Intermediate Similarity | NPC324033 |
0.7368 | Intermediate Similarity | NPC321458 |
0.7329 | Intermediate Similarity | NPC164665 |
0.7267 | Intermediate Similarity | NPC21448 |
0.7267 | Intermediate Similarity | NPC156461 |
0.7267 | Intermediate Similarity | NPC107374 |
0.7222 | Intermediate Similarity | NPC189068 |
0.7178 | Intermediate Similarity | NPC219313 |
0.7178 | Intermediate Similarity | NPC269827 |
0.7178 | Intermediate Similarity | NPC309832 |
0.7143 | Intermediate Similarity | NPC229974 |
0.7101 | Intermediate Similarity | NPC239737 |
0.7019 | Intermediate Similarity | NPC161659 |
0.7019 | Intermediate Similarity | NPC209525 |
0.7006 | Intermediate Similarity | NPC85689 |
0.7006 | Intermediate Similarity | NPC185991 |
0.7006 | Intermediate Similarity | NPC211025 |
0.6964 | Remote Similarity | NPC472816 |
0.6964 | Remote Similarity | NPC321814 |
0.6946 | Remote Similarity | NPC150853 |
0.6933 | Remote Similarity | NPC314152 |
0.6923 | Remote Similarity | NPC302778 |
0.6923 | Remote Similarity | NPC212551 |
0.6923 | Remote Similarity | NPC130586 |
0.6923 | Remote Similarity | NPC164952 |
0.6914 | Remote Similarity | NPC317821 |
0.6882 | Remote Similarity | NPC174802 |
0.6842 | Remote Similarity | NPC224076 |
0.6826 | Remote Similarity | NPC121222 |
0.6802 | Remote Similarity | NPC316618 |
0.6802 | Remote Similarity | NPC226245 |
0.6748 | Remote Similarity | NPC129756 |
0.6706 | Remote Similarity | NPC161224 |
0.6689 | Remote Similarity | NPC329046 |
0.661 | Remote Similarity | NPC323091 |
0.6588 | Remote Similarity | NPC136349 |
0.6564 | Remote Similarity | NPC320818 |
0.6485 | Remote Similarity | NPC33996 |
0.6474 | Remote Similarity | NPC328479 |
0.6463 | Remote Similarity | NPC61198 |
0.6419 | Remote Similarity | NPC163105 |
0.6402 | Remote Similarity | NPC262926 |
0.6378 | Remote Similarity | NPC189261 |
0.6341 | Remote Similarity | NPC319221 |
0.6328 | Remote Similarity | NPC93365 |
0.6324 | Remote Similarity | NPC326529 |
0.6292 | Remote Similarity | NPC195140 |
0.629 | Remote Similarity | NPC319100 |
0.629 | Remote Similarity | NPC324198 |
0.6287 | Remote Similarity | NPC30326 |
0.628 | Remote Similarity | NPC324009 |
0.6257 | Remote Similarity | NPC274384 |
0.6257 | Remote Similarity | NPC89147 |
0.6237 | Remote Similarity | NPC313897 |
0.6209 | Remote Similarity | NPC324484 |
0.6199 | Remote Similarity | NPC211820 |
0.6199 | Remote Similarity | NPC251233 |
0.6196 | Remote Similarity | NPC290959 |
0.6196 | Remote Similarity | NPC326082 |
0.6176 | Remote Similarity | NPC186619 |
0.6175 | Remote Similarity | NPC325906 |
0.6163 | Remote Similarity | NPC177169 |
0.6127 | Remote Similarity | NPC64705 |
0.6127 | Remote Similarity | NPC232408 |
0.6114 | Remote Similarity | NPC250178 |
0.6107 | Remote Similarity | NPC75844 |
0.6105 | Remote Similarity | NPC318590 |
0.6102 | Remote Similarity | NPC321052 |
0.6082 | Remote Similarity | NPC313514 |
0.6069 | Remote Similarity | NPC317746 |
0.6047 | Remote Similarity | NPC315642 |
0.6047 | Remote Similarity | NPC74306 |
0.6013 | Remote Similarity | NPC27699 |
0.5917 | Remote Similarity | NPC107160 |
0.5854 | Remote Similarity | NPC248007 |
0.5846 | Remote Similarity | NPC24589 |
0.5838 | Remote Similarity | NPC14590 |
0.5838 | Remote Similarity | NPC78941 |
0.5838 | Remote Similarity | NPC282458 |
0.5825 | Remote Similarity | NPC103388 |
0.5825 | Remote Similarity | NPC157821 |
0.581 | Remote Similarity | NPC326694 |
0.5805 | Remote Similarity | NPC276373 |
0.5777 | Remote Similarity | NPC5802 |
0.5695 | Remote Similarity | NPC160666 |
0.568 | Remote Similarity | NPC287876 |
0.5671 | Remote Similarity | NPC139776 |
0.5621 | Remote Similarity | NPC14330 |
0.5614 | Remote Similarity | NPC57279 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC321393 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8176 | Intermediate Similarity | NPD1692 | Approved |
0.8038 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD218 | Approved |
0.773 | Intermediate Similarity | NPD219 | Phase 3 |
0.773 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD216 | Approved |
0.773 | Intermediate Similarity | NPD217 | Approved |
0.7546 | Intermediate Similarity | NPD214 | Approved |
0.7546 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD1046 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD4089 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD8827 | Approved |
0.7412 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD1063 | Phase 2 |
0.7267 | Intermediate Similarity | NPD250 | Approved |
0.7267 | Intermediate Similarity | NPD249 | Approved |
0.7178 | Intermediate Similarity | NPD195 | Approved |
0.7178 | Intermediate Similarity | NPD186 | Discovery |
0.7069 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7013 | Intermediate Similarity | NPD8826 | Approved |
0.7006 | Intermediate Similarity | NPD283 | Approved |
0.6933 | Remote Similarity | NPD185 | Approved |
0.6923 | Remote Similarity | NPD338 | Approved |
0.6923 | Remote Similarity | NPD1750 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD242 | Approved |
0.6923 | Remote Similarity | NPD3107 | Discontinued |
0.6923 | Remote Similarity | NPD1369 | Phase 2 |
0.6882 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.6882 | Remote Similarity | NPD339 | Approved |
0.6848 | Remote Similarity | NPD166 | Approved |
0.6842 | Remote Similarity | NPD169 | Phase 2 |
0.681 | Remote Similarity | NPD193 | Suspended |
0.6802 | Remote Similarity | NPD2646 | Discontinued |
0.6802 | Remote Similarity | NPD2624 | Phase 2 |
0.6802 | Remote Similarity | NPD1732 | Phase 3 |
0.6721 | Remote Similarity | NPD4716 | Approved |
0.6705 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD4744 | Clinical (unspecified phase) |
0.6588 | Remote Similarity | NPD548 | Clinical (unspecified phase) |
0.6562 | Remote Similarity | NPD9632 | Phase 3 |
0.6463 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6413 | Remote Similarity | NPD5666 | Phase 2 |
0.6404 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD420 | Discontinued |
0.6333 | Remote Similarity | NPD9071 | Phase 3 |
0.6328 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.629 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.6278 | Remote Similarity | NPD3083 | Approved |
0.6264 | Remote Similarity | NPD7988 | Suspended |
0.6257 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6225 | Remote Similarity | NPD9416 | Phase 3 |
0.6225 | Remote Similarity | NPD9417 | Phase 3 |
0.6213 | Remote Similarity | NPD549 | Approved |
0.6205 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6175 | Remote Similarity | NPD1776 | Approved |
0.6175 | Remote Similarity | NPD1777 | Approved |
0.6159 | Remote Similarity | NPD248 | Discontinued |
0.6158 | Remote Similarity | NPD3593 | Approved |
0.6114 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD5682 | Phase 3 |
0.6107 | Remote Similarity | NPD8566 | Approved |
0.6102 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.6082 | Remote Similarity | NPD7138 | Phase 2 |
0.6047 | Remote Similarity | NPD582 | Approved |
0.6037 | Remote Similarity | NPD8832 | Approved |
0.6013 | Remote Similarity | NPD8571 | Phase 3 |
0.5987 | Remote Similarity | NPD9406 | Approved |
0.5969 | Remote Similarity | NPD2632 | Approved |
0.5969 | Remote Similarity | NPD2630 | Approved |
0.5969 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.5965 | Remote Similarity | NPD6351 | Discovery |
0.5951 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.5943 | Remote Similarity | NPD1730 | Discontinued |
0.5939 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.5934 | Remote Similarity | NPD4074 | Clinical (unspecified phase) |
0.5931 | Remote Similarity | NPD5486 | Discontinued |
0.5922 | Remote Similarity | NPD2876 | Phase 3 |
0.5922 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.5922 | Remote Similarity | NPD9605 | Phase 3 |
0.5906 | Remote Similarity | NPD799 | Phase 1 |
0.5894 | Remote Similarity | NPD796 | Phase 2 |
0.5888 | Remote Similarity | NPD537 | Phase 2 |
0.5888 | Remote Similarity | NPD534 | Phase 2 |
0.5879 | Remote Similarity | NPD9366 | Approved |
0.5866 | Remote Similarity | NPD3086 | Phase 3 |
0.5865 | Remote Similarity | NPD2824 | Phase 2 |
0.5854 | Remote Similarity | NPD9084 | Phase 2 |
0.5845 | Remote Similarity | NPD5458 | Discontinued |
0.581 | Remote Similarity | NPD3085 | Phase 1 |
0.5755 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5755 | Remote Similarity | NPD2902 | Phase 2 |
0.5729 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD1367 | Phase 2 |
0.568 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5678 | Remote Similarity | NPD8373 | Clinical (unspecified phase) |
0.5673 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5636 | Remote Similarity | NPD306 | Approved |
0.5621 | Remote Similarity | NPD9633 | Phase 3 |
0.5618 | Remote Similarity | NPD7158 | Phase 1 |
0.5616 | Remote Similarity | NPD4187 | Clinical (unspecified phase) |
0.5602 | Remote Similarity | NPD1734 | Clinical (unspecified phase) |
PubChem CID   | |
ChEMBL   | CHEMBL1688966 |
ZINC   |
Molecular Weight:   | 268.08 |
ALogP:   | -1.9895 |
MLogP:   | 1.57 |
XLogP:   | -2.06 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 133.75 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 4 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |